Literature DB >> 6128043

alpha-Adrenoceptor blocking properties of raubasine in pithed rats.

P Demichel, P Gomond, J Roquebert.   

Abstract

1 Raubasine was compared with yohimbine and corynanthine in pithed rats. Antagonist activity at alpha 1-adrenoceptors was evaluated on the pressor response to electrical stimulation of the spinal sympathetic outflow and to phenylephrine administration, both being reduced by raubasine in the dose range 1 to 4 mg/kg. Corynanthine was quantitatively similar, but yohimbine was not only less potent but also in doses of 0.125 to 0.5 mg/kg enhanced the effects of electrical stimulation. 2 Antagonist activity at alpha 2-adrenoceptors was determined against the inhibitory effects of clonidine on tachycardia induced by electrical stimulation of cardiac sympathetic nerves and against the pressor responses to B-HT-933 injection. Raubasine up to 4 mg/kg, like corynanthine, did not affect the pressor responses to B-HT-933 nor did it reduce the inhibitory effect of clonidine. By contrast yohimbine reduced the response to BHT-933 and antagonized clonidine as well as enhancing the tachycardia caused by electrical stimulation. 3 The results indicate that, in vivo, raubasine, like corynanthine, is a selective antagonist at alpha 1-adrenoceptors and that yohimbine is more potent in blocking alpha 2-than alpha 1-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6128043      PMCID: PMC2044614          DOI: 10.1111/j.1476-5381.1982.tb09317.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  17 in total

Review 1.  Regulation of noradrenaline release by presynaptic receptor systems.

Authors:  K Starke
Journal:  Rev Physiol Biochem Pharmacol       Date:  1977       Impact factor: 5.545

2.  Pre- and postsynaptic effects of yohimbine stereoisomers on noradrenergic transmission in the pulmonary artery of the rabbit.

Authors:  R Weitzell; T Tanaka; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-08       Impact factor: 3.000

3.  Further sub-classification of alpha-adrenoceptors in the cardiovascular system, vas deferens and anococcygeus of the rat [proceedings].

Authors:  J R Docherty; A MacDonald; J C McGrath
Journal:  Br J Pharmacol       Date:  1979-11       Impact factor: 8.739

4.  A functional basis for classification of alpha-adrenergic receptors.

Authors:  S Berthelsen; W A Pettinger
Journal:  Life Sci       Date:  1977-09-01       Impact factor: 5.037

5.  Pharmacological characterization of B-HT 933 (2-amino-6-ethyl-4,5,7,8,-tetrahydro-6H-oxazolo-[5,4-d]-azepindihydrochloride) as a hypotensive agent of the "clonidine-type".

Authors:  W Kobinger; L Pichler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-10       Impact factor: 3.000

6.  Relative pre- and postsynaptic potencies of alpha-adrenoceptor agonists in the rabbit pulmonary artery.

Authors:  K Starke; T Endo; H D Taube
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

Review 7.  Presynaptic regulation of catecholamine release.

Authors:  S Z Langer
Journal:  Biochem Pharmacol       Date:  1974-07-01       Impact factor: 5.858

8.  A method of stimulating the complete sympathetic outflow from the spinal cord to blood vessels in the pithed rat.

Authors:  J S Gillespie; T C Muir
Journal:  Br J Pharmacol Chemother       Date:  1967-05

9.  Effects of clonidine and guanethidine on peripheral sympathetic nerve function in the pithed rat.

Authors:  J M Armstrong; A L Boura
Journal:  Br J Pharmacol       Date:  1973-04       Impact factor: 8.739

10.  Plasma catecholamine and blood pressure responses to sympathetic stimulation in pithed rats.

Authors:  I Yamaguchi; I J Kopin
Journal:  Am J Physiol       Date:  1979-09
View more
  3 in total

1.  Difference in the potency of alpha 2-adrenoceptor agonists and antagonists between the pithed rabbit and rat.

Authors:  J M Bulloch; J R Docherty; N A Flavahan; J C McGrath; C E McKean
Journal:  Br J Pharmacol       Date:  1987-07       Impact factor: 8.739

2.  An exploration of the potential mechanisms and translational potential of five medicinal plants for applications in Alzheimer's disease.

Authors:  Taner Shakir; Ahmed Y Coulibaly; Patrick G Kehoe
Journal:  Am J Neurodegener Dis       Date:  2013-06-21

3.  Case Report: Treatment of Kratom Use Disorder With a Classical Tricyclic Antidepressant.

Authors:  Alessandro E Vento; Simone de Persis; Sergio De Filippis; Fabrizio Schifano; Flavia Napoletano; John M Corkery; Georgios D Kotzalidis
Journal:  Front Psychiatry       Date:  2021-03-31       Impact factor: 4.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.